Arca
Skip to content

Invisalign System with Mandibular Advancement Feature

Aligner, Sequential. 510(k) K181739, from Align Technology, Inc. (San Jose, CA). Product code NXC, class 2.

As of Nov 17, 2026, K181739 is an FDA 510(k) held by Align Technology, Inc., substantially equivalent on Oct 26, 2018 after 116 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Oct 26, 2018
  • Review time: 116 days
  • Recalls: 0
  • Cited as a predicate by: 4 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The Invisalign System is indicated for the orthodontic treatment of malocclusion.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

4 later 510(k) summaries name this device as a predicate

Other NXC Clearances

The newest 510(k)s for the same product code; their median review was 127 days; see every NXC device

Record

Type
Traditional
Received
Jul 2, 2018
Review panel
Dental
Regulation
21 CFR 872.5470

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.